(No ratings)
Dr. Alan D. Michelson, MD is a pediatric oncologist in Boston, MA specializing in pediatric hematology/oncology. He graduated from The University of Adelaide Faculty of Health Sciences. Dr. Alan D. Michelson, MD is affiliated with Dana-Farber Cancer Institute.
450 BROOKLINE AVENUE
Boston, MA 02215
300 Longwood Avenue
Boston, MA 02115
Anemia
Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.
An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.
Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.
Platelet Disorders
Platelet disorders are conditions caused by abnormally low or high levels of platelets in the blood, or by platelets that do not function correctly. Platelets are small blood cells that help stop bleeding by clumping together and forming blood clots, allowing the body to heal.
Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.
Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:
If a doctor suspects a patient has a platelet disorder, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Platelet disorders can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights. Tests measuring prothrombin time (PT), or how long it takes for blood to clot, can also detect dysfunctional platelets. If platelets do not coagulate within a certain time frame, the patient most likely has dysfunctional platelets.
Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.
Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.
Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Patients with high blood count are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with platelet disorders can live healthy and fulfilling lives with proper treatment and precautions.
Dr. Alan D. Michelson, MD graduated from The University of Adelaide Faculty of Health Sciences. He completed residency at The Children's Hospital, Sydney, Pediatrics. He has a state license in Massachusetts.
Medical School: The University of Adelaide Faculty of Health Sciences
Residency: The Children's Hospital, Sydney, Pediatrics
Licensed In: Massachusetts
Dr. Alan D. Michelson, MD is associated with these hospitals and organizations:
Dr. Alan D. Michelson, MD does not have any reviews yet, be the first to leave a review of Dr. Alan D. Michelson, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Alan D. Michelson, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
AstraZeneca UK Limited |
$16,781
BRILINTA $16,781 |
||
---|---|---|---|
Medtronic Vascular, Inc. |
$16,515
HeartWare HVAD $1,250 |
$15,265 |
|
Janssen Research & Development, LLC |
$14,949
XARELTO $9,785 |
$5,164 |
|
AstraZeneca AB |
$10,162
BRILINTA $3,604 |
$6,558 |
|
Eli Lilly and Company |
$8,875
Effient $8,875 |
||
Other |
$15,408
KENGREAL $2,762 |
NA $1,500 |
$11,145 |
Consulting Fee | $62,922 |
---|---|
Travel and Lodging | $11,663 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,880 |
Honoraria | $1,500 |
Food and Beverage | $724 |
Dr. Alan D. Michelson, MD has received 33 research payments totaling $1,141,180.
Dr. Alan Michelson practices pediatric hematology/oncology in Boston, MA. Clinical interests for Dr. Michelson include anemia. Dr. Michelson is professionally affiliated with Dana-Farber Cancer Institute. He has an open panel in Boston, MA according to Doctor.com.